High TS gene expression in tumours was associated with enhanced benefit from post-operative adjuvant S-1 treatment in gastric cancer [51], and might predict drug resistance and adverse prognosis in patients with advanced stages treated with FU-based CT [52]. Here, TYMS is linked to gastric cancer.